HotSpot presents preclinical data from small molecule CBM signalosome inhibitor programme at ESMO Gastrointestinal ...
HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting Smart Allostery platform-identified regulatory sites on proteins referred to as “natural hotspots,” …